Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2007
08/02/2007US20070178166 Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
08/02/2007US20070178165 Processes for making particle-based pharmaceutical formulations for parenteral administration
08/02/2007US20070178164 Pharmaceutical formulations of oxcarbazepine and methods for its preparation
08/02/2007US20070178163 Gas dispersion manufacture of nanoparticulates, and nanoparticulate-containing products and processing thereof
08/02/2007US20070178162 Process for production of ionically crosslinked polysaccharide microspheres
08/02/2007US20070178161 Use of n-acetryl-d-glucosamine in treating and controlling non-specific inflammations caused by physical or chemical factors
08/02/2007US20070178160 Gastro-intestinal device and method for treating addiction
08/02/2007US20070178159 In-Situ Forming Porous Scaffold
08/02/2007US20070178158 Stabilized bone graft
08/02/2007US20070178157 Process for cleaning hard gelatine capsules
08/02/2007US20070178156 Pharmaceutical formulations
08/02/2007US20070178155 Preparation for gastric buoyant sustained drug release dosage form
08/02/2007US20070178154 Calcium Carbonate Granulation
08/02/2007US20070178153 Calcium Carbonate Granulation
08/02/2007US20070178152 Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents
08/02/2007US20070178151 Spray dried pharmaceutical compositions
08/02/2007US20070178150 Pharmaceutical compositions
08/02/2007US20070178149 Levodopa compositions
08/02/2007US20070178148 Preparations of growth hormone
08/02/2007US20070178147 Liposomal compositions
08/02/2007US20070178144 Cold-preparable, low-viscosity and prolonged-stability cosmetic emulsions
08/02/2007US20070178141 Vitamin B12 compositions
08/02/2007US20070178139 Vaginally administratable progesterone-containing tablets and method for preparing same
08/02/2007US20070178124 Inorganic phosphates reversibly grafted with bioactive compounds and a method of their preparation
08/02/2007US20070178123 Flavor-enhancing compositions, method of manufacture, and methods of use
08/02/2007US20070178119 Veterinary medicine; brain disorders; immunizing with vaccine comprising West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil carrier
08/02/2007US20070178070 Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
08/02/2007US20070178068 Compositions and methods for regulating complement system
08/02/2007US20070178056 Mixture comprising a detergent and a co-detergent
08/02/2007US20070178052 Delivery of opioids through an inhalation route
08/02/2007US20070178051 Sterilized nanoparticulate glucocorticosteroid formulations
08/02/2007US20070178050 Methods and systems for the delivery of corticosteroids having an increased lung depositon
08/02/2007US20070178049 Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
08/02/2007US20070178048 administering an effective amount of p-menthane-3,8-diol (PMD) to destroy, inactivate, or inhibit the growth or reproduction of a virus (influenza virus, A/Sydney/5/97 virus, Urbani SARS virus and HSV-1 virus); antiseptic and antifungal agent; PMD rich extract derived from lemon eucalyptus
08/02/2007US20070175472 Dpi formulation containing sulfoalkyl ether cyclodextrin
08/02/2007DE19934943B4 Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen Cosmetic and dermatological preparations based on O / W emulsions
08/02/2007DE10230558B4 Medizinisches Set zur Verabreichung in einer Kombinationstherapie Medical set for administration in combination therapy
08/02/2007DE102006004353A1 Kaltherstellbare, niedrigviskose und langzeitstabile kosmetische Emulsionen Recoverable cold, low and stable long-term cosmetic emulsions
08/02/2007DE102006003512A1 Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen Plate-like drugs for transbukkalen application of drugs
08/02/2007CA2676483A1 Surface-layer protein coated microspheres and uses thereof
08/02/2007CA2656829A1 Foaming granule and method for making same
08/02/2007CA2640529A1 Chewable capsules
08/02/2007CA2640376A1 Antimicrobial ceramic material comprising metal species
08/02/2007CA2640165A1 A method of producing porous microparticles
08/02/2007CA2640069A1 Chewable compositions comprising a gelled oil-in-water emulsion
08/02/2007CA2639406A1 Methods of increasing oral bioavailability of tetracyclines
08/02/2007CA2637925A1 Levetiracetam formulations and methods for their manufacture
08/02/2007CA2637300A1 Pharmaceutical forms in film form for use in the mouth (wafers)
08/02/2007CA2637275A1 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
08/02/2007CA2637274A1 Soft-gelatin capsule formulation
08/02/2007CA2607494A1 Nanoparticulate clopidogrel formulations
08/01/2007EP1813295A2 Coated surgical needles
08/01/2007EP1813288A1 Medicinal composition, medicinal preparation, and combination preparation
08/01/2007EP1813287A1 Type ii cubic liquid crystal composition
08/01/2007EP1813277A1 Dispenser for dispensing two or more substances
08/01/2007EP1813276A1 Tamper resistant dosage forms
08/01/2007EP1813275A1 Lansoprazole orally disintegrating tablets
08/01/2007EP1813274A1 Medicinal composition, process for producing the same, and method of stabilizing dihydropyridine compound in medicinal composition
08/01/2007EP1813273A1 Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
08/01/2007EP1813272A1 Veterinary use of a lleuromutilin derivate againts ileitis in swine
08/01/2007EP1813268A1 Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds
08/01/2007EP1812864A2 Multifunctional nanoparticles conjugates and their use
08/01/2007EP1812494A1 Microparticles and nanoparticles containing a lipopolymer
08/01/2007EP1812115A2 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy
08/01/2007EP1812079A2 Pharmaceutical mixture evaluation
08/01/2007EP1812052A1 Methods of cancer treatment/prevention using cancer cell-specific surface antigens
08/01/2007EP1812040A2 Synergistic effects of combined administration of mirtazapine and a stimulant compound
08/01/2007EP1812032A2 Tissue factor composition and methods
08/01/2007EP1812022A2 Stand-alone film and methods for making the same
08/01/2007EP1812000A1 Aqueous ophthalmic suspension of crystalline rebamipide
08/01/2007EP1811995A1 A transmucosal veterinary composition comprising detomidine
08/01/2007EP1811986A1 Gabapentin prodrug sustained release oral dosage forms
08/01/2007EP1811981A2 Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
08/01/2007EP1811979A2 Microcapsules comprising a methylxanthine and a corticosteroid
08/01/2007EP1811978A1 Production of double- or multi-layered microcapsules
08/01/2007EP1811977A2 High concentration self-microemulsifying coenzyme q10 preparations for nutritional use
08/01/2007EP1811976A1 Immediate release film coating
08/01/2007EP1811975A2 Enteric coated compositions that release active ingredient(s) in gastric fluid and intestinal fluid
08/01/2007EP1811974A2 Pharmaceutical analysis apparatus and method
08/01/2007EP1811973A1 Pharmaceutical compositions comprising (+) - (2s, 3s) - 2 - (chlorophenyl) - 3, 5, 5-trimethhyl-2-morpholinol
08/01/2007EP1811972A1 A controlled slow release formulation of thiamine and use thereof in the treatment of pathologies connected to defective process of learning and memorization
08/01/2007EP1811971A2 Dosage forms having a microreliefed surface and methods and apparatus for their production
08/01/2007EP1811970A2 Dosage forms having a microreliefed surface and methods and apparatus for their production
08/01/2007EP1811969A2 Dosage forms having a microreliefed surface and methods and apparatus for their production
08/01/2007EP1811968A2 Dosage forms having a microreliefed surface and methods and apparatus for their production
08/01/2007EP1811967A2 Methods and formulations for making pharmaceutical compositions containing bupropion
08/01/2007EP1811966A2 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
08/01/2007EP1811965A1 A process for preparing formulations of lipophilic active substances by spray freeze drying
08/01/2007EP1811964A1 Granular compositions comprising solidified melt granules of a cox-2 selective inhibitor
08/01/2007EP1811963A2 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
08/01/2007EP1811962A2 Manufacturing process for liposomal preparations
08/01/2007EP1811961A2 Extended surface aggregates in the treatment of skin conditions
08/01/2007EP1811960A2 Improvements in or relating to pharmaceutical compositions for local administration
08/01/2007EP1811959A2 Ophthalmic compositions and methods for treating eyes
08/01/2007EP1811958A2 Removal of impurities with supercritical fluids from ocular drug delivery devices during manufacturing
08/01/2007EP1811957A1 Solid pharmaceutical composition comprising donepezil hydrochloride
08/01/2007EP1811956A1 Method of reducing nosocomial infections
08/01/2007EP1811941A2 Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
08/01/2007EP1811855A1 Food supplement containing fish oil
08/01/2007EP1638395A4 Physical mode of action pesticide